Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.02
-0.03-2.86%
At close: -
$1.04
0.021.96%
After Hours: May 30, 8:07 AM EDT
Comments
Loading...
Acumen Pharmaceuticals Stock Price, Quotes and Forecasts
ABOSNASDAQ
Acumen Pharmaceuticals (ABOS) Forecast
NewsEarningsAcumen Pharmaceuticals (ABOS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Acumen Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:ABOS | Benzinga
Explore Acumen Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ABOS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Acumen Pharmaceuticals (ABOS) stock?
You can purchase shares of Acumen Pharmaceuticals (NASDAQ:ABOS) through any online brokerage.
Who are Acumen Pharmaceuticals (ABOS) competitors?
Other companies in Acumen Pharmaceuticals’s space includes: Zura Bio (NASDAQ:ZURA), Serina Therapeutics (AMEX:SER), Skye Bioscience (NASDAQ:SKYE), Fortress Biotech (NASDAQ:FBIO) and Immuneering (NASDAQ:IMRX).
What is the forecast, or price target, for Acumen Pharmaceuticals (ABOS) stock?
Acumen Pharmaceuticals has a consensus price target of $11.50.
What is the current price for Acumen Pharmaceuticals (ABOS)?
The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $1.04 last updated May 30, 2025 at 8:07 AM EDT.
Does Acumen Pharmaceuticals (ABOS) pay a dividend?
There are no upcoming dividends for Acumen Pharmaceuticals.
When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?
Acumen Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 12, 2025.
Is Acumen Pharmaceuticals (ABOS) going to split?
There is no upcoming split for Acumen Pharmaceuticals.
What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?
Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
